Emory University: Stress Disorders, Post-Traumatic trials

The registry lists 33 Stress Disorders, Post-Traumatic studies with Emory University as lead sponsor. 10 are open to participants now and 12 have results posted.

Early Phase 1 1Phase 1 4Phase 2 8Phase 3 2Phase 4 3No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The PREVENT Resilience StudyRecruitingNCT07568145Not applicable
• Temporal Interference in Psychiatry (TIP): Neuromodulation Using Temporal InterferenceRecruitingNCT07558759Not applicable
• Psilocybin-Assisted TherapyRecruitingNCT07332143Phase 2
• MDMA-Assisted Massed Exposure Therapy for PTSDRecruitingNCT07288151Phase 2
• PTSD Screening in Pregnant Black WomenRecruitingNCT06522022Not applicable
• MDMA Plus Exposure Therapy for PTSDEnrolling by invitationNCT05746572Phase 2
• Disrupting Fear-based Memory ConsolidationRecruitingNCT05560113Not applicable
• Mechanistic Interventions and Neuroscience of DissociationRecruitingNCT04670640Not applicable
• Role of Sympathetic Overactivity and Angiotensin II in PTSD and CVRecruitingNCT02560805Phase 2
• Sympathetic Overactivity in Post-traumatic Stress DisorderRecruitingNCT01627301Not applicable
• Transcranial Direct Current Stimulation Treatment for Warriors Experiencing Chronic PainCompletedNCT05254379Not applicableResults posted
• Effect of TMS on PTSD BiomarkersCompletedNCT04563078Not applicableResults posted
• Neuroendocrine Risk for PTSD in WomenCompletedNCT03973229Early Phase 1Results posted
• Primary-Care Based Mindfulness InterventionCompletedNCT03922581Not applicableResults posted
• Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress DisorderCompletedNCT02992899Phase 3Results posted
• Physiological Augmentation of Mindfulness MeditationCompletedNCT02754557Not applicableResults posted
• Tapering Off AntidepressantsTerminatedNCT02661828Not applicableResults posted
• Dexamethasone Plus Virtual Reality Exposure Therapy for PTSDCompletedNCT01965366Phase 4Results posted
• Neural Circuits in Women With Abuse and Posttraumatic Stress DisorderCompletedNCT01681849Phase 4Results posted
• Cortisol Suppression and Startle Responses in Posttraumatic Stress Disorder (PTSD)CompletedNCT01477762Not applicableResults posted
• Evaluation of GSK561679 in Women With Post-Traumatic Stress DisorderCompletedNCT01018992Phase 2Results posted
• D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSDCompletedNCT00356278Phase 2/3Results posted
• BraveMind: Advancing the Virtual Iraq/Afghanistan PTSD Exposure TherapyCompletedNCT02246972Phase 2
• Meditation for Emotional Numbing in Post-Traumatic Stress DisorderCompletedNCT02163941Phase 1
• Optimal Dose of Early Intervention to Prevent PTSDCompletedNCT01959620Not applicable
• Norepinephrine Transporter Availability in PTSDCompletedNCT01799837Phase 1
• Community-Based Telemedicine to Reduce Risk to Georgia Veterans With Post Traumatic Stress DisorderWithdrawnNCT01623219Not applicable
• Examining the Effectiveness of an Early Psychological Intervention to Prevent Post-Traumatic Stress DisorderCompletedNCT00895518Phase 1
• Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)CompletedNCT00672776Phase 4
• Evaluating the Effects of Stress in PregnancyCompletedNCT00525226
• Fear Potentiation and Fear Inhibition in Posttraumatic Stress DisorderCompletedNCT00209040Not applicable
• Mental Health Symptoms and Intimate Partner ViolenceCompletedNCT00166075
• Civilian Post-Traumatic Stress Disorder Risperidone Clinical TrialCompletedNCT00133822Phase 1/2